Most recent update: Thursday, April 18, 2019 - 10:50

Bariatric News - Cookies & privacy policy

- News

A literature review by researchers looking at the complex relationship between obesity, various rheumatic diseases and bariatric surgery has underscored the need to establish long-term prospective controlled trials evaluate the risk-benefit ratio of... (more)

16/04/19 - News

Young people with cognitive impairments and developmental disabilities (CI/DD), including Down syndrome, have similar weight-loss trajectories to those with typical cognitive function after bariatric surgery, according to a study by psychologists at Children's National Health... (more)
12/04/19 - News

The State of Kuwait Ministry of Health and Dendrite Clinical Systems, in conjunction with Bader Sultan & Brothers Company, are delighted to announce the publication of the First Kuwait National Bariatric Registry Report 2019, the first ever national report on bariatric and... (more)
10/04/19 - News

One-year outcomes from over 47,000 Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy procedures has reported that RYGB resulted in a higher rate of patients with total weight loss (TWL) >20% (95.8% vs 84.6%, p<0.001). However, there were no significant differences... (more)

Product approval

16/04/19

Gelesis has gained FDA approval for its lead product candidate, PLENITY (Gelesis100), as an aid in weight management in adults with a BMI25–40,...

05/04/19 - News

Researchers from Harvard Medical School have made key new insights into the molecular behaviour of insulin via an unexpected mechanism by which insulin triggers changes to the expression of thousands of genes throughout the genome. Their analyses show that the insulin receptor... (more)
05/04/19 - News

In the years following bariatric surgery, a person's overall eating behaviours and the amount of time spent watching television, playing video games and using a computer for recreation are a better indication of long-term weight loss success than specific weight control... (more)
04/04/19 - News

Gelesis has announced clinical data from its pivotal Gelesis Loss of Weight (GLOW) study suggesting that elevated fasting plasma glucose could be a useful and unique predictor to identify individuals who have higher adjusted odds to achieve significant weight loss with... (more)

More news

04/04/19 - Research
Gelesis hydrogel
Gelesis has announced clinical data from its pivotal Gelesis Loss of Weight (GLOW) study suggesting that elevated fasting plasma glucose could be a useful and unique predictor to identify individuals who have higher adjusted odds to achieve significant weight loss with Gelesis100. As observed in a... (more)
04/04/19 - Event
Event preview
It is my honour, privilege and great pleasure to invite you to the ‘London International Bariatric Symposium’ to be held at Homerton University Hospital on Thursday, 21st and Friday, 22nd November, 2019. Sanjay Agrawal_small.jpg Sanjay Agrawal The symposium will... (more)
04/04/19 - Research
GERD treatments and costs
Treatment with the LINX Reflux Management System reduced medical costs more than laparoscopic Nissen fundoplication (LNF), a more invasive anti-reflux surgery, and more than offsets the slightly higher cost of the procedure, according to a study presented at the 2019 Annual Meeting of the Society... (more)
03/04/19 - Event
European Obesity Day
European Obesity Day, held each year to draw attention to Europe’s growing obesity epidemic and the need for better prevention and treatment, is to be held this year on Saturday 18 May. Individuals, healthcare providers and organisations throughout Europe will be taking part with events ranging... (more)
03/04/19 - Research
BEAT Obesity
Although bariatric embolization is unlikely to promote weight loss as effectively as bariatric surgery, it is at least as effective as some pharmacotherapies (ie, liraglutide, orlistat, lorcaserin), which induce mean weight loss of 2%–9% (28), according to researchers from the Bariatric... (more)
02/04/19 - Research
ENDURE II Trial
ReShape Lifesciences announced that the company has successfully implanted its first patient in the ENDURE II trial designed to support CE Marking of the ReShape Vest. The ReShape Vest System is an investigational, minimally invasive, laparoscopically implanted medical device that wraps around the... (more)